Literature DB >> 8036809

The mechanism of low testosterone levels in homozygous sickle-cell disease.

O Parshad1, M C Stevens, M A Preece, P W Thomas, G R Serjeant.   

Abstract

Significantly lower testosterone levels are common in male patients with homozygous sickle-cell (SS) disease and have been attributed to either abnormalities of the hypothalamo-pituitary axis or primary testicular failure. The mechanism has now been investigated by observing the response to gonadotropin-thyrotropin releasing hormones (GnRH-TRH) in 10 male patients with SS disease and in 10 matched male sibling controls without sickle-cell disease. Mean basal levels of luteinizing hormone (LH), follicular stimulating hormone (FSH) and thyrotropin (TSH) were significantly elevated but prolactin (PRL) levels were within the normal range in the SS group. All hormones increased following GnRH-TRH, and proportionate increases over baseline were similar for FSH and TSH in SS and AA subjects, but SS patients showed a lesser percentage increase in LH at 30 minutes, and a higher percentage increase in PRL at 60 minutes. These observations are more consistent with primary testicular failure than with abnormalities of the hypothalamic-pituitary-testicular axis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036809

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  7 in total

1.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

2.  Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease?

Authors:  Belinda F Morrison; Uzoma A Anele; Marvin E Reid; Wendy A Madden; Zhaoyong Feng; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-11-05       Impact factor: 2.370

Review 3.  Testosterone replacement therapy and erectile dysfunction.

Authors:  Ifeanyi C Onyeji; Raul I Clavijo
Journal:  Int J Impot Res       Date:  2022-01-08       Impact factor: 2.896

Review 4.  Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation.

Authors:  Biljana Musicki; Arthur L Burnett
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

5.  Serum testosterone levels of HbSS (sickle cell disease) male subjects in Lagos, Nigeria.

Authors:  Emmanuel K Abudu; Sulaiman A Akanmu; Oyetunji O Soriyan; Akinsegun A Akinbami; Adewumi Adediran; Titilope A Adeyemo; Charles C Okany
Journal:  BMC Res Notes       Date:  2011-08-17

6.  Mechanism of testosterone deficiency in the transgenic sickle cell mouse.

Authors:  Biljana Musicki; Yuxi Zhang; Haolin Chen; Terry R Brown; Barry R Zirkin; Arthur L Burnett
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

7.  Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: Effects on pituitary gonadal axis and sperm parameters; A pilot study.

Authors:  Ashraf Soliman; Mohamed Yassin; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2014-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.